Pfizer, Germany's Merck to Develop Tumor Treatment

Pfizer and Germany’s Merck are teaming up to develop a new tumor treatment product, in a move that will boost the U.S. company’s oncology business but reduce its full-year earnings per share.



from WSJ.com: US Business http://ift.tt/1EQvkTi

via IFTTT